1 month All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy Zacks
Quest Diagnostics (DGX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.
Earnings · Quest Diagnostics (DGX)
X